1. Home
  2. LNTH vs LITE Comparison

LNTH vs LITE Comparison

Compare LNTH & LITE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • LITE
  • Stock Information
  • Founded
  • LNTH 1956
  • LITE 2015
  • Country
  • LNTH United States
  • LITE United States
  • Employees
  • LNTH N/A
  • LITE N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • LITE Telecommunications Equipment
  • Sector
  • LNTH Health Care
  • LITE Telecommunications
  • Exchange
  • LNTH Nasdaq
  • LITE Nasdaq
  • Market Cap
  • LNTH 5.7B
  • LITE 6.5B
  • IPO Year
  • LNTH 2015
  • LITE N/A
  • Fundamental
  • Price
  • LNTH $70.57
  • LITE $106.68
  • Analyst Decision
  • LNTH Strong Buy
  • LITE Buy
  • Analyst Count
  • LNTH 5
  • LITE 15
  • Target Price
  • LNTH $131.20
  • LITE $86.71
  • AVG Volume (30 Days)
  • LNTH 1.1M
  • LITE 2.1M
  • Earning Date
  • LNTH 08-06-2025
  • LITE 08-12-2025
  • Dividend Yield
  • LNTH N/A
  • LITE N/A
  • EPS Growth
  • LNTH N/A
  • LITE N/A
  • EPS
  • LNTH 3.53
  • LITE N/A
  • Revenue
  • LNTH $1,536,699,000.00
  • LITE $1,472,600,000.00
  • Revenue This Year
  • LNTH $4.57
  • LITE $22.06
  • Revenue Next Year
  • LNTH $9.41
  • LITE $31.95
  • P/E Ratio
  • LNTH $19.99
  • LITE N/A
  • Revenue Growth
  • LNTH 12.53
  • LITE 3.58
  • 52 Week Low
  • LNTH $69.12
  • LITE $38.29
  • 52 Week High
  • LNTH $118.21
  • LITE $114.12
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 35.55
  • LITE 66.36
  • Support Level
  • LNTH $70.40
  • LITE $107.89
  • Resistance Level
  • LNTH $73.52
  • LITE $114.12
  • Average True Range (ATR)
  • LNTH 2.48
  • LITE 4.16
  • MACD
  • LNTH -0.27
  • LITE 0.27
  • Stochastic Oscillator
  • LNTH 10.21
  • LITE 62.42

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About LITE Lumentum Holdings Inc.

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

Share on Social Networks: